US Stock MarketDetailed Quotes

Spero Therapeutics (SPRO)

Watchlist
  • 2.820
  • -0.160-5.37%
Close Jun 5 16:00 ET
  • 2.900
  • +0.080+2.84%
Post 20:01 ET
163.28MMarket Cap10.44P/E (TTM)

Spero Therapeutics (SPRO) Earnings Dates, Reports & Conference Call

SPRO 2026 Q1 Earnings Dates & Summary

Currency:USDMay 13, 2026

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
--
258.00K
--
-95.61%
Net Income
--
-7.20M
--
+48.05%
No Data

SPRO Revenue, EPS and EBIT Estimates

Revenue

Net Profit

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Nov 13, 20252025/Q35.442M / 0.000--
Aug 12, 20252025/Q214.189M / 0.000--
May 13, 20252025/Q15.874M / 0.000--
Mar 27, 20252024/Q415.044M / 6.200M--
Nov 14, 20242024/Q313.469M / 7.667M--
DatePeriodRevenue/EstimateEarnings Call
Nov 13, 20252025/Q35.442M / 0.000--
Aug 12, 20252025/Q214.189M / 0.000--
May 13, 20252025/Q15.874M / 0.000--
Mar 27, 20252024/Q415.044M / 6.200M--
Nov 14, 20242024/Q313.469M / 7.667M--

Unlock Free Earnings Estimates

Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On June 3, Eastern Time, the U.S. House of Representatives passed a resolution limiting Trump's authority to use military force against Iran Show More